From Liston Street Pulse:
Last week, Illumina Inc. (ILMN) shares surged as investors cheered the company's quarterly results. The results highlight the growth in molecular diagnostics. Illumina registered a 25% increase in its third-quarter revenue. The company's GAAP net income for the quarter was $31 million, or $0.22 per share, compared to $30 million, or $0.22 […]
The post Illumina's Strong Results Highlight Growth in Molecular Diagnostics appeared first on Liston Street Pulse.
Created by Stock Researching | Dec 13, 2016
Created by Stock Researching | Dec 04, 2016
Created by Stock Researching | Dec 02, 2016
Created by Stock Researching | Nov 19, 2016
Created by Stock Researching | Nov 10, 2016
Created by Stock Researching | Oct 05, 2015